Jyoti CNC Q3 FY26 results: Revenue up 32 percent, PAT up 36 percent YoY

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionExceptional ItemResults View source PDF Explain this filing

JYOTICNC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.7%Reaction day

₹861.00

prior close

₹858.95

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.5%-4.2% vs market

Industrial Products peers, median of 123sector+0.5%-4.3% vs sector

On the reaction day the stock moved 4.2 pts less than Nifty Smallcap 250 and 4.3 pts less than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.6

10m

+0.4

15m

+1.2

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.7+0.5-4.2+0.5-4.3

Next day

-0.1+0.6-0.8-0.0-0.1

-1.3-0.1-1.1-0.8-0.4

-3.8-1.7-2.1-1.9-1.9

-3.7-1.8-2.0-2.6-1.1

-2.2-1.0-1.2-2.0-0.2

-1.9-1.7-0.1-4.3+2.4

15d

-7.0-6.3-0.7-9.0+2.0

-8.7-5.4-3.2-7.8-0.8

-5.1-3.2-1.9-3.8-1.2

-13.0+6.1-19.1+3.4-16.4

UpDownMarket · Nifty Smallcap 250Sector · Industrial Products peers, median of 123Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jyoti CNC reported Q3 FY26 standalone revenue of 529.77 Cr, up about 32 percent YoY, with PAT of 105.16 Cr, up about 36 percent. Nine month FY26 standalone revenue grew about 24 percent to 1,350.31 Cr and PAT rose about 36 percent to 256.22 Cr. Consolidated nine month revenue was 1,493.97 Cr, up about 20 percent, with PAT of 245.43 Cr. Auditor G.K. Choksi and Co. issued an unmodified limited review opinion. Management did not impair its investment in a loss making subsidiary, citing expected recovery.

Likely market impact

Strong revenue and profit growth with margin expansion supports the stock. Non provision of subsidiary impairment is a watch point for investors.